Innovating Works
PeptiCHIP: Pre-clinical validation and demonstration of PeptiCHIP: an immunopurification microfluidic device an... VALO THERAPEUTICS OY tramitó un HORIZON EUROPE HORIZON-EIC-2022-TRANSITION-01 Clinical translation of cancer immunotherapies remains very challenging since 60-80% of patients fail to respond. The challenge stands in id...
2023-03-13 - 2025-03-31 | Financiado
BRAINSTORM: Wireless deep BRAIN STimulation thrOugh engineeRed Multifunctinal nanomaterials VALO THERAPEUTICS OY participó en un HORIZON EUROPE HORIZON-EIC-2022-PATHFINDEROPEN-01 BRAINSTORM will introduce an innovative, scalable, wireless, multimodal nanoinvasive neuromodulation technology suitable for independent and...
2022-12-08 - 2027-03-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.